David A. Holmes was named president and chief executive on June 19, 2026, and the board added two directors in July and August. Second quarter results followed on July 30, 2026, with first-half revenue of USD 6.7 million, down 16%, and a net loss …
Per the 8-K dated October 13, 2026, Alaunos Therapeutics (NASDAQ:TCRT) completed its acquisition of Velaris Therapeutics through a two-step merger. Merger consideration was 105,286 Series B and 33,054 Series C non-voting convertible preferred shares, each convertible into 1,000 common shares. Investors bought 687,789 common …
No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026. The latest company news is a September 9, 2026 liquid cooling supply contract for an AI data center pilot, signed by Trinovium, a subsidiary launched on June 23, 2026. …
No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026. Published market data show 43.51 million shares traded, equal to USD 16.75 million of turnover at USD 0.385, own arithmetic. A later quote showed 48.69 million shares against a …
Published market data shows a 19.10% rise to USD 3.59 on 866,670 shares. A relative volume of 0.57 implies average volume of 1.52 million shares (own arithmetic). Turnover was USD 3.11 million (own arithmetic, price times volume), or 1.65% of the USD 188.12 million …
Published market data shows USD 2.31, up 16.66%, on 12.13 million shares; session date and average volume were not stated. Turnover is USD 28.0 million (own arithmetic), or 154% of the USD 18.13 million market value. Volume exceeds the implied 7.85 million share count …
AIxCrypto Holdings disclosed a term sheet on September 28, 2026 to merge with and restructure on the robotics subsidiary of Faraday Future Intelligent Electric (NASDAQ:FFAI). The company was renamed FF EAI Robotics Ecosystem Inc. and began trading as FFR on September 30, 2026. Faraday …
Published market data shows a 14.81% rise to USD 2.48 on 239,250 shares, against a relative volume of 0.29, which implies average volume of 825,000 shares (own arithmetic). Turnover was USD 593,340 (own arithmetic, price times volume), or 14.2% of the USD 4.17 million …
China SXT Pharmaceuticals (NASDAQ:SXTC) announced the offering on October 8, 2026, with closing expected on October 9. Investors hold an option to buy up to another USD 12 million on the same terms during the 30 days after closing. The release does not state …
No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026. The 13.67% gain came on 62.55 thousand shares, which is USD 46,224 of turnover at USD 0.739, own arithmetic. Relative volume of 0.68 implies average volume of 91,985 shares, …